Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study › Research Explorer

DOI

https://doi.org/10.1097/QAI.0000000000000523
Final published version

Mathias Bruyand
Lene Ryom
Leah Shepherd
Gerd Fatkenheuer
Andrew Grulich
Peter Reiss
Stéphane de Wit
Antonella D Arminio Monforte
Hansjakob Furrer
Christian Pradier
Jens Lundgren
Caroline Sabin
AUTHOR GROUP

Original language	English
Pages (from-to)	568-577
Journal	Journal of acquired immune deficiency syndromes (1999)
Volume	68
Issue number	5
DOIs	https://doi.org/10.1097/QAI.0000000000000523
Publication status	Published - 2015

ID: 2591473